Research Areas

We are dedicated to developing evidence-based and clinically validated software that can not only halt but reverse the progression of diseases, ultimately leading to an improved quality of life for patients.

Chronic Diseases

According to World Health Organization (WHO) premature death from or living long term with a noncommunicable disease (NCD) and its related disability has put an increasing strain on health systems, economic development and the well-being of large parts of the population. Consequently, NCDs are one of the major challenges for sustainable development in the 21st century. 

 

The four major NCDs are cardiovascular diseases, diabetes mellitus, cancers and chronic respiratory disease. They are associated with a cluster of common risk factors, such as tobacco and alcohol use, unhealthy diets, physical inactivity, hypertension, obesity and environmental factors.

0

million adults (20-79 years) have Impaired Glucose Tolerance (IGT)

0

million adults (20-79 years) are living with Diabetes - 1 in 10

0 %

Diabetes related health expenditure increase over the last 15 years

Our Focus

Prediabetes is a condition defined as having blood glucose levels above normal but below the defined threshold of diabetes mellitus.

Type 2 diabetes is a condition in which the body becomes resistant to the normal effects of insulin and gradually loses the capacity to produce enough insulin in the pancreas.

Weight that is higher than what is considered healthy for a given height is described as overweight or obesity. Body Mass Index (BMI) is a screening tool for overweight and obesity.

Metabolic syndrome is a clustering of at least three of the following five medical conditions: abdominal obesity, high blood pressure, high blood sugar, high serum triglycerides, and low serum high-density lipoprotein (HDL).

Gestational diabetes is a type of diabetes that can develop during pregnancy in women who don’t already have diabetes.

Pipeline

Pipeline snapshot as of March 31, 2023

TH-001 Prediabetes
Clinical Trial
TH-002 Type 2 Diabetes
Prototype
TH-003 Obesity
Pre-clinical Research
TH-004 Metabolic Syndrome
Concept
TH-005 Gestational Diabetes
Discovery
Scroll to Top